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Abstract 24 
The importance of folate during pregnancy was established more than 80 years ago 25 
by Lucy Wills’ ground-breaking studies of tropical macrocytic anaemia. More recently, 26 
it has become apparent that the adverse consequences of inadequate nutrient 27 
supply during early developmental may be exacerbated by over-nutrition post-natally. 28 
This paper aims to recent evidence that maternal methyl donor (notably folate) 29 
supply peri-conceptually and during pregnancy has long-term effects on offspring 30 
(metabolic) health. In addition, we propose the hypothesis that epigenetic 31 
mechanisms, especially DNA methylation, may mediate the effects of these early life 32 
nutritional insults.  We discuss evidence from a natural experiment in humans which 33 
provides proof of principle for the hypothesis. We describe an attempt to test this 34 
hypothesis using a mouse model in which female C57Bl/6 mice were randomized to 35 
low or normal folate diets (0.4 or 2 mg folic acid/kg diet) prior to, and during, 36 
pregnancy and lactation. At 4 weeks of age, offspring were randomized to high- or 37 
low-fat diets. Low maternal folate supply resulted in offspring that were more 38 
susceptible to detrimental metabolic effects of a high-fat diet fed from weaning, 39 
manifested as increased circulating triacylglycerols (TAG) concentration. 40 
Interestingly, this metabolic phenotype in adult offspring occurred without any 41 
detectable change in adiposity, suggesting a different etiological origin from the more 42 
commonly reported observation that maternal under-nutrition leads to increased 43 
offspring adiposity and to symptoms of the Metabolic Syndrome. The widespread 44 
prevalence of overweight and obesity and of folate deficiency among women of 45 
child-bearing age highlights the possibility that this double nutritional insult may 46 
exacerbate the risk of metabolic disease in their offspring. 47 
  48 
 49 
 50 
In 1928, Lucy Wills, a young English doctor, travelled to India to investigate an 51 
unusual form of anaemia (later called tropical macrocytic anaemia) which was 52 
common during pregnancy in women working in the textile mills. At first, she 53 
investigated intestinal infections as a possible cause of the anaemia but later 54 
became convinced that the disease had a nutritional aetiology. Following successful 55 
studies with a rat model of anaemia in pregnancy which could be prevented by 56 
adding yeast to the diet, Wills began human studies in which she gave anaemic 57 
women yeast or a yeast extract and examined the haematological responses(1) . As 58 
she reported in her classical paper in 1931, yeast extract (supplied by the Marmite 59 
Food Extract Company) was highly effective in resolving the anaemia(2). On her 60 
return to the Pathology Department at the Royal Free Hospital in London, Wills 61 
continued to investigate the curative factor in yeast using rhesus monkeys as 62 
models(3) but it was not until 1945 that other researchers in the USA isolated and 63 
identified a new B vitamin which we know as folate(4).The availability of a synthetic 64 
form of the vitamin, folic acid, facilitated further studies of the biochemistry of folate 65 
and the discovery of its central role in one-carbon metabolism.  66 
In the 1960s, low maternal folate status was linked with increased risk of neural tube 67 
defects (NTDs)(5) and this association led, eventually, to randomised controlled trials 68 
(RCTs) which demonstrated the efficacy of supplementation with relatively large 69 
doses of folic acid in reducing both NTD recurrence(6) and occurrence(7). These   70 
ground-breaking RCTs provided the evidence base for national-scale public health 71 
interventions, initially in the USA and Canada, which require the mandatory 72 
fortification of flour with 140 μg of folic acid per 100 g flour. This fortification 73 
programme, which began in 1996 and became mandatory from January 1998, has 74 
been highly effective in raising the folate status of the whole population(8) and has 75 
been associated with a substantial fall in NTD prevalence(9). Several other countries, 76 
excluding those in the European Union, have implemented similar folic acid 77 
fortification policies.  78 
Early life origins of metabolic diseases 79 
Folate and one-carbon metabolism is now seen as an integrator of nutrient status 80 
through which changes in nutrient inputs have multiple health effects via multiple 81 
changes in cell processes(10) (Fig.1). For example, because its role as a source of 82 
methyl groups for the re-methylation of homocysteine to methionine (Fig 2), low 83 
folate supply leads to elevated concentrations of homocysteine(11) which are 84 
associated with increased risk of NTDs, cardiovascular disease, cancers, dementias 85 
and osteoporosis(12). In India and other Asian countries, the prevalence of type 2 86 
diabetes and other metabolic diseases is rising rapidly, apparently as a consequence 87 
of the double nutritional insults of poor maternal nutrition followed by over-nutrition 88 
associated with urbanisation and the adoption of higher fat diets(13). More specifically, 89 
the observation that raised maternal homocysteine concentration in pregnancy is 90 
associated with low birthweight has been confirmed by Mendelian randomisation 91 
analysis supports a causal role for dysregulated one-carbon metabolism in poor fetal 92 
growth(14). In addition, abnormal folate and homocysteine concentrations in mothers 93 
during pregnancy associate with both small birth size and increased likelihood of 94 
childhood insulin resistance in the offspring, emphasising the potential for 95 
nutritionally-driven disturbances in one-carbon metabolism to enhance fetal 96 
programming of diabetes and other metabolic diseases(15). These observations fit 97 
with the “predictive adaptive response” hypothesis which proposes that mismatch 98 
between the environment anticipated by the fetus, based on early (in utero) 99 
environmental exposures, and the environment encountered post-natally may 100 
predispose to the early development of metabolic, and other, diseases(16). Therefore 101 
the adverse consequences of inadequate nutrient (folate) supply during early 102 
developmental may be exacerbated by over-nutrition post-natally. Whilst the 103 
mechanisms responsible for the lifelong consequences of adverse nutritional 104 
exposures in early life are poorly understood, it seems probable that they include 105 
epigenetic processes (17) . 106 
 107 
Epigenetics as a mechanism linking early life nutrition with later health 108 
Epigenetics describes an integrated system of marks (DNA methylation and post-109 
translational modification of histones) and molecules (including small non-coding 110 
RNAs) which is responsible for regulating the transcriptional state of individual cells. 111 
Importantly, epigenetic mechanisms are responsive to the cell’s environment and so 112 
are modulated by dietary and other exposures(18).  The importance of the maternal 113 
intake of folate and other methyl donors during pregnancy on DNA methylation 114 
patterns and offspring phenotype was established more than a decade ago using the 115 
agouti (A(vy)) mice which have a transposable element in the agouti gene(19). 116 
Maternal supplementation with folic acid, vitamin B12, choline, and betaine increased 117 
CpG methylation at the A(vy) locus in the offspring and increased the proportion of 118 
leaner offspring with darker coats(19). The agouti locus is an example of a metastable 119 
epiallele (ME) that is variably expressed in genetically identical individuals due to 120 
epigenetic modifications that were established during early development(20). In 121 
humans, Waterland and colleagues were the first to establish that the maternal 122 
environment around the time of conception influences the methylation status of 123 
MEs in the offspring(21).  This work was undertaken in rural Gambia where seasonal 124 
differences in work patterns, food availability and other environmental factors provide 125 
a natural experiment for testing the effects of maternal exposures on pregnancy 126 
outcomes. Although in such natural experiments it is impossible to determine which 127 
of the many factors is responsible for a given outcome, it seems likely that nutrition is 128 
important. For example, seasonal differences in maternal consumption of methyl-129 
donor nutrients influenced the maternal plasma concentrations of multiple substrates 130 
for one-carbon metabolism during pregnancy and these changes were reflected in 131 
altered methylation of MEs in DNA extracted from lymphocytes and from hair follicles 132 
in their infant offspring(22). More recent study of these Gambian children revealed that 133 
methylation of the tumour suppressor gene VTRNA2-1 differed according to season 134 
of conception (23). In addition, once altered in utero, the methylation status of 135 
VTRNA2-1 was stable over at least 10 years(23).  VTRNA2-1 is a ME which appears 136 
to influence both cancer risk and immune function and the authors argued that this 137 
season of birth-related epigenetic change is a plausible candidate pathway to explain 138 
their earlier observation that season of birth predicts adult mortality from infection-139 
related causes in rural Gambians(24).  Whilst these exciting findings should stimulate 140 
further investigations of the impact of peri-conceptual nutrition on health outcomes 141 
and the possible mediating effects of epigenetic mechanisms, the results should be 142 
interpreted with caution since they demonstrate associations but not causality. 143 
Towards a mouse model for testing the effects of maternal folate inadequacy 144 
on the metabolic health of the offspring 145 
Direct testing in humans of the effects of maternal folate inadequacy on the 146 
metabolic health of the offspring is fraught with obvious ethical and practical 147 
difficulties. In addition, attempts to investigate the epigenetic mechanisms through 148 
which such nutritional insults during early development produce their long-term 149 
effects on health(25) in humans would require access to tissue such as liver and 150 
placenta. This is because the patterns of epigenetic marks, notably DNA methylation, 151 
are cell and tissue specific so that methylation marks assessed in a surrogate tissue 152 
e.g. blood or buccal cells may not reflect those in the cell or tissue of interest(26). For 153 
example, we quantified DNA methylation by pyrosequencing® for a panel of genes 154 
including Esr1, Igf2 and Slc39a4 using DNA extracted from blood, liver, and kidney 155 
from female mice and observed tissue-specific differences in methylation at all loci(26). 156 
Such inter-tissue differences in DNA methylation patterns in humans were confirmed 157 
for IGF2, GNASAS and IL10 by Waterland and colleagues who examined 158 
methylation patterns in post-mortem samples of brain, liver and kidney obtained from 159 
Vietamese motor vehicle accident victims(21). In addition, we observed that folate 160 
depletion during pregnancy altered Igf2 methylation in a tissue-specific manner 161 
(p<0.05)(26). In this context, MEs are a special case since their methylation status is 162 
very similar in all tissues investigated and methylation changes induced in early 163 
development appear to be stable indefinitely(23). As a consequence, suitable animal 164 
models are necessary to test for causality, to undertake investigations of possible 165 
epigenetic mechanisms and to augment the epidemiological evidence available from 166 
human studies.  167 
In recently completed work, we set out to test 3 hypotheses: 168 
1. Maternal folate depletion during pregnancy and lactation may contribute to the 169 
development of obesity and the Metabolic Syndrome (MS); 170 
2. These effects may be exacerbated by provision of a high fat diet post-weaning 171 
(double nutritional insult); 172 
3. The altered phenotype may be due to altered gene expression through 173 
epigenetic mechanisms. 174 
On the basis that better models facilitate better hypothesis testing, we developed a 175 
mouse model of maternal folate depletion which was uncomplicated by other factors. 176 
In addition, because epigenetic processes may be particular plastic in early 177 
embryonic/ fetal life, we considered it important that the mouse dams were folate 178 
depleted at mating. To minimise potential confounding by other factors, the degree of 179 
folate depletion should be sufficient to impose a nutritional stress but not be so 180 
severe as to limit reproduction. Finally, by feeding a high-fat diet from weaning, we 181 
aimed to simulate a common secondary nutrition stress. Such a model may yield 182 
data which may be more readily interpretable mechanistically and which are likely to 183 
be of greater relevance to human nutrition i.e. more potential for translation.  184 
Our first question was how long would it take to induce folate-depletion in young 185 
female mice? We addressed this question by feeding female mice a folate-free diet 186 
for up to 7 weeks(25). Blood was collected from pairs of culled mice weekly and red 187 
blood cell (RBC) folate concentration measured. As shown in Fig 3, there were 2 188 
distinct phases in RBC folate kinetics; an initial phase lasting approximately 2 weeks 189 
during which RBC folate concentration remained largely unchanged followed by 190 
exponential “decay” in RBC folate concentration toward a new equilibrium after 4-5 191 
weeks(25). For comparison, Leamon and colleagues reported that RBC folate 192 
reached a new (lower) plateau in BALB/c mice approximately 6 week after transfer to 193 
a low folate diet(27). Further studies showed that a milder nutritional insult (feeding 194 
0.4 mg folic acid/ kg diet) reduced maternal and offspring RBC folate concentrations 195 
(measured at weaning) by about 50%(25). 196 
For the remaining studies described in this report, we adopted a 2*2 factorial design 197 
in which female C57/Bl6 mice were fed a folate-normal or folate-depleted diet (2 and 198 
0.4 mg folic acid/ kg diet respectively) for 4-5 weeks before mating and throughout 199 
pregnancy and lactation. At weaning, offspring were randomised to either a control 200 
(CONT) diet or a high fat (HF) diet (50 and 200g fat/kg diet respectively) from 201 
weaning until aged 6 months (Fig 4)(28,29). For dams with successful pregnancies, 202 
duration of dietary exposure did not differ between those fed the normal and low-203 
folate diets (p=0.42). However, dams fed the low-folate diet were more likely to 204 
experience reproductive failure due to miscarriage or postpartum litter death(29). At 205 
weaning, maternal serum folate concentration was reduced by approximately two 206 
thirds (P< 0.001) in the dams fed the low-folate diet confirming the magnitude of the 207 
maternal dietary insult(29). Whilst the low-folate diet had no effect on litter size, body 208 
weight at weaning was 6% lower for offspring of mothers fed the low-folate diet(29).  209 
As expected, offspring randomised to the high-fat (HF) diet were heavier and 210 
contained more body fat at ages 3 and 6 months than those randomised to the 211 
lower-fat (CONT) diet but there was no effect of maternal folate depletion on 212 
offspring adult weight or adiposity(29). In addition, there was no effect of maternal 213 
folate supply on the gross anatomy of the 6 month old offspring as gauged by organ 214 
weights and gut lengths(29). However, adult offspring from dams fed the folate-215 
depleted diet had significantly raised plasma triacylglycerol (TAG) concentrations 216 
when given the HF diet from weaning whereas the HF diet had no effect on TAG 217 
concentrations in the offspring of mothers with adequate folate supply before mating 218 
and during pregnancy and lactation (Pinteraction = 0.005)(29). This provided evidence 219 
that the early life nutritional insult (maternal folate depletion during pregnancy and 220 
lactation) had long-term adverse metabolic consequences for the offspring which 221 
were revealed only when the offspring were exposed to a second nutritional insult i.e. 222 
HF feeding from weaning. This adverse metabolic phenotype in the adult offspring 223 
occurred in the absence of a detectable effect on adiposity which suggests a 224 
different aetiological origin from the frequently reported phenotype characterised by 225 
enhanced adiposity and other symptoms of the Metabolic Syndrome (MS) in the 226 
adult offspring of dams exposed to malnutrition during pregnancy(30).   227 
Investigation of possible mechanism(s) for long-term metabolic effect on 228 
offspring of folate depletion during pregnancy and lactation 229 
We hypothesised that maternal folate depletion alters folate supply to the embryo 230 
and the developing fetus with potential widespread effects because of its impact on 231 
one-carbon metabolism. In particular, inadequate folate limits the availability of 232 
methyl groups for S-adenosylmethionine (SAM) synthesis and this generates 233 
competition between cellular processes which use SAM, notably the methylation of 234 
macromolecules including lipids, proteins and DNA. Further, we hypothesised that 235 
reduced SAM availability would alter the pattern of DNA methylation which, because 236 
of its role in regulating transcription, would change the repertoire of expressed 237 
genes(31). Finally, the altered gene expression would reduce the capacity of adult 238 
offspring to cope metabolically with a second nutritional stress, e.g. HF feeding, 239 
leading to elevated plasma TAG concentrations. If these putative effects were 240 
induced in early life, we anticipated that they might be detectable in the fetus late in 241 
pregnancy and that this might be an informative life-stage at which to test our 242 
hypothesis.  243 
Using time-mated dams, we collected fetuses and their placentae at pregnancy day 244 
17.5. Both tissues were used for investigation of genome-wide gene expression and, 245 
in addition, genome-wide promoter methylation was investigated in the fetal livers. 246 
The outcomes of those mechanistic studies will be published elsewhere. We 247 
observed no effect of maternal folate depletion on placental mass or placental 248 
efficiency (McKay, Ford & Mathers, unpublished) suggesting that the maternal 249 
nutritional insult did not disadvantage the offspring through a gross effect on 250 
placental size or function. Similarly, there was no effect on fetal liver mass. Using 251 
genome-wide microarray approaches, we investigated gene expression in both 252 
tissues and found that approximately twice as many genes were differentially 253 
expressed in the fetal liver (nearly 1000) than in the placenta (<500) in response to 254 
maternal folate depletion. In both tissues, approximately equal proportions of genes 255 
were up- and down-regulated. However, the particular genes which were 256 
differentially expressed in the two tissues were almost totally different and only 4 257 
genes showed concordant expression changes in both liver and placenta. These 258 
observations support the hypothesis that when folate supply is limiting during fetal 259 
development, gene expression changes are tissue specific. Such specificity in 260 
response to a nutritional challenge may have survival advantage with the “short-lived” 261 
placenta responding very differently from the liver where changes in phenotype may 262 
have lifelong implications.   263 
Genome-wide DNA methylation analysis by microarray showed that >300 genes 264 
were differentially methylated in the fetal liver from folate-depleted dams and, 265 
curiously, most of these genes were hyper-methylated. There was limited overlap 266 
between the genes which were differentially methylated and those which were 267 
differentially expressed which suggests that these epigenetic changes were not 268 
responsible for most the observed transcriptional changes. This may be because 269 
changes in transcription factors, microRNA or other regulatory mechanisms caused 270 
the changes in gene expression when folate supply was inadequate or that the 271 
nutritional insult altered methylation of CpG sites which were not assayed by the 272 
microarray used in this study.  273 
Public health implications 274 
Adequate folate intake pre-conception and during pregnancy and lactation is 275 
essential for good maternal and child health. Recent data from the National Diet and 276 
Nutrition Survey Rolling programme shows widespread folate inadequacy among 277 
women of child-bearing age in the UK (Table 1)(32). Biochemical folate deficiency is 278 
more prevalent in younger, than in older, women and in Scotland and Northern 279 
Ireland than in the UK as a whole. In addition, overweight and obesity are common 280 
among women of child-bearing age(33). The Health Survey for England reported that 281 
14% of females aged 16 - 24 years were obese and that this rose to almost 25% for 282 
women aged 35-44 years(33). If the observations from our mouse study(29) apply in 283 
humans, then the combination of folate deficiency and excess adiposity among 284 
women of child-bearing age may disadvantage the health of their offspring by 285 
increasing the risk of metabolic diseases exemplified by raised TAG concentrations. 286 
This risk may be exacerbated if the folate needs of obese women are greater than 287 
those of normal weight women. A study of short-term folate pharmacokinetics in 288 
women of child-bearing age showed that the-area-under-the-curve (AUC) for the 289 
absorption phase (0-3h) and the peak serum folate concentration were both 290 
significantly lower in obese women following consumption of 400μg folic acid – the 291 
recommended supplemental dose to lower NTD risk (Fig. 4)(34). In a previous study 292 
in which the folic acid dose administered was calculated per total body weight, the 293 
AUC was higher in obese women and the authors suggested that it would be 294 
preferable to define the folate dose in relation to lean body weight(35). In summary, 295 
folate recommendations for obese women of reproductive age may need to be 296 
reconsidered to ensure adequacy. 297 
In conclusion, our mouse studies showed that uncomplicated folate inadequacy peri-298 
conceptually and during pregnancy and lactation predisposed the offspring to 299 
metabolic derangements when fed a high fat diet. The widespread prevalence of 300 
folate deficiency and of overweight and obesity among women of child-bearing age 301 
highlights the possibility that this double nutritional insult may exacerbate the risk of 302 
metabolic disease in their offspring and points to the need for appropriate 303 
interventions. 304 
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 308 
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  422 
Table 1. Percentages of women of child-bearing age with evidence of biochemical 423 
folate deficiency based on serum and red blood cell (RBC) folate concentrations 424 
(NDNS Rolling Programme 2015) 425 
Age range 16-24 years 25-34 years 34-49 years 
Serum folate* 22.1 17.7 13.1 
RBC folate† 15.6 9.5 10.1 
* Percentage of women with serum folate concentration < 10nM(36). 426 
† Percentage of women with RBC folate concentration < 340nM(36). 427 
  428 
Figure legends 429 
Fig. 1. Overview of one-carbon metabolism indicating its role as an integrator 430 
of nutrient status (from Reference 10)  431 
Fig. 2. Role of folate in one-carbon metabolism supplying methyl groups for 432 
multiple purposes (from Reference 11) 433 
Fig. 3. Study design investigating effects of maternal folate depletion and high 434 
fat feeding from weaning (from Reference 28) 435 
Fig. 4. Serum folate responses following ingestion of 400μg folic acid in obese 436 
and normal weight women (from Reference 34) 437 
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